Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Dermatitis
ADR ID BADD_A01214
ADR Hierarchy
23      Skin and subcutaneous tissue disorders
23.03      Epidermal and dermal conditions
23.03.04      Dermatitis and eczema
23.03.04.002      Dermatitis
Description Inflammation involving the skin of the extremities, especially the hands and feet. Several forms are known, some idiopathic and some hereditary. The infantile form is called Gianotti-Crosti syndrome. [MeSH]
MedDRA Code 10012431
MeSH ID D000169; D003872
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Acrodermatitis | Dermatitic reaction of face | Dermatitic reaction of neck | Dermatitis | Dermatitis autosensitization | Dermatitis due to other specified substances taken internally | Dermatitis due to substances taken internally | Dermatitis due to unspecified substance taken internally | Dermatitis flare-up | Dermatitis NOS | Dermatitis NOS aggravated | Dermatitis simplex erythematosa | Inflammation dorsum of left foot | Rash and other nonspecific skin eruption | Skin inflammation NOS | Dermatitis (NOS) | Dermatitis autosensitisation | Skin inflammation | Interface dermatitis | Keratodermatitis | Steroid dermatitis | Acrodermatitides | Gianotti-Crosti Syndrome | Gianotti Crosti Syndrome | Syndrome, Gianotti-Crosti | Acropapulo-Vesicular Syndrome | Acropapulo Vesicular Syndrome | Acropapulo-Vesicular Syndromes | Syndrome, Acropapulo-Vesicular | Syndromes, Acropapulo-Vesicular | Papulovesicular Acrolocated Syndrome | Papulovesicular Acrolocated Syndromes | Syndromes, Papulovesicular Acrolocated | Infantile Papular Acrodermatitis | Infantile Papular Acrodermatitides | Papular Acrodermatitides, Infantile | Papular Acrodermatitis, Infantile | Papular Acrodermatitis of Childhood | Childhood Papular Acrodermatitides | Childhood Papular Acrodermatitis | Acrodermatitis Papulosa Infantum | Acrodermatitis Papulosa Infantums | Erythemato-Vesiculo-Papulous Eruptive Syndrome | Erythemato Vesiculo Papulous Eruptive Syndrome | Erythemato-Vesiculo-Papulous Eruptive Syndromes | Syndrome, Erythemato-Vesiculo-Papulous Eruptive | Syndromes, Erythemato-Vesiculo-Papulous Eruptive
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02023Silver--
BADD_D02025Simeprevir--
BADD_D02026Simvastatin0.000025%
BADD_D02027Sincalide--
BADD_D02028Sirolimus--
BADD_D02029Sitagliptin--
BADD_D02031Sitaxentan--
BADD_D02033Sodium aurothiomalate--
BADD_D02037Sodium cation--
BADD_D02038Sodium ferric gluconate complex--
BADD_D02041Sodium iodide--
BADD_D02053Sofosbuvir0.000706%
BADD_D02058Sorafenib0.000560%
BADD_D02060Sotalol0.000281%
BADD_D02062Sparfloxacin--
BADD_D02066Spironolactone0.000037%
BADD_D02068Stavudine--
BADD_D02069Stiripentol--
BADD_D02070Streptokinase--
BADD_D02072Streptomycin sulfate--
BADD_D02076Strontium ranelate--
BADD_D02078Succimer--
BADD_D02079Succinylcholine--
BADD_D02082Sufentanil--
BADD_D02090Sulfadiazine--
BADD_D02091Sulfamethoxazole--
BADD_D02093Sulfasalazine0.000667%
BADD_D02096Sulfur hexafluoride--
BADD_D02097Sulindac--
BADD_D02098Sumatriptan--
The 36th Page    First    Pre   36 37 38 39 40    Next   Last    Total 42 Pages